Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration.

Ghosh MC, Collins GD, Vandanmagsar B, Patel K, Brill M, Carter A, Lustig A, Becker KG, Wood WW 3rd, Emeche CD, French AD, O'Connell MP, Xu M, Weeraratna AT, Taub DD.

Blood. 2009 Aug 13;114(7):1366-73. doi: 10.1182/blood-2008-08-175869.

2.

Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.

Jin Z, Zhao C, Han X, Han Y.

BMC Cancer. 2012 Oct 18;12:480. doi: 10.1186/1471-2407-12-480.

3.

Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.

Chen G, Chen SM, Wang X, Ding XF, Ding J, Meng LH.

J Biol Chem. 2012 Apr 6;287(15):12132-41. doi: 10.1074/jbc.M111.302299. Erratum in: J Biol Chem. 2012 Jun 1;287(23):19336.

4.

The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.

Yuan Y, Niu CC, Deng G, Li ZQ, Pan J, Zhao C, Yang ZL, Si WK.

Int J Mol Med. 2011 Jan;27(1):63-9. doi: 10.3892/ijmm.2010.560.

PMID:
21069266
5.

An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis.

Hanaki H, Yamamoto H, Sakane H, Matsumoto S, Ohdan H, Sato A, Kikuchi A.

Mol Cancer Ther. 2012 Feb;11(2):298-307. doi: 10.1158/1535-7163.MCT-11-0682.

6.
7.

The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.

Zhuo W, Jia L, Song N, Lu XA, Ding Y, Wang X, Song X, Fu Y, Luo Y.

Clin Cancer Res. 2012 Oct 1;18(19):5387-98. doi: 10.1158/1078-0432.CCR-12-0708.

8.

Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.

Kim J, Kim J, Kim DW, Ha Y, Ihm MH, Kim H, Song K, Lee I.

J Immunol. 2010 Jul 15;185(2):1274-82. doi: 10.4049/jimmunol.1000181.

9.

Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase.

Ottoson NC, Pribila JT, Chan AS, Shimizu Y.

J Immunol. 2001 Aug 15;167(4):1857-61.

10.

Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.

Song ZY, Gao ZH, Chu JH, Han XZ, Qu XJ.

Biomed Pharmacother. 2015 Apr;71:46-52. doi: 10.1016/j.biopha.2015.01.020.

PMID:
25960214
11.

Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma.

Bi L, Liu X, Wang C, Cao Y, Mao R, Li P, Geng M.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):987-95.

12.

Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.

Hsiao JJ, Ng BH, Smits MM, Wang J, Jasavala RJ, Martinez HD, Lee J, Alston JJ, Misonou H, Trimmer JS, Wright ME.

BMC Cancer. 2015 Mar 31;15:204. doi: 10.1186/s12885-015-1201-5.

13.

Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.

Bakker ER, Das AM, Helvensteijn W, Franken PF, Swagemakers S, van der Valk MA, ten Hagen TL, Kuipers EJ, van Veelen W, Smits R.

Carcinogenesis. 2013 Nov;34(11):2629-38. doi: 10.1093/carcin/bgt215.

14.

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.

Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W, Kikuchi A.

Oncogene. 2010 Apr 8;29(14):2036-46. doi: 10.1038/onc.2009.496.

PMID:
20101234
15.

Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.

Prgomet Z, Axelsson L, Lindberg P, Andersson T.

J Oral Pathol Med. 2015 Nov;44(10):776-84. doi: 10.1111/jop.12292.

PMID:
25459554
16.

Redundant expression of canonical Wnt ligands in human breast cancer cell lines.

Benhaj K, Akcali KC, Ozturk M.

Oncol Rep. 2006 Mar;15(3):701-7.

PMID:
16465433
17.

Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2.

Masckauchán TN, Agalliu D, Vorontchikhina M, Ahn A, Parmalee NL, Li CM, Khoo A, Tycko B, Brown AM, Kitajewski J.

Mol Biol Cell. 2006 Dec;17(12):5163-72.

18.

Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.

Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, Tasdemir N, Yilmaz M, Erdal E, Akcali KC, Atabey N, Ozturk M.

Mol Cancer. 2009 Oct 22;8:90. doi: 10.1186/1476-4598-8-90.

19.
20.

WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.

Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, Andersson T, Leandersson K.

Mol Cancer. 2014 Apr 26;13:88. doi: 10.1186/1476-4598-13-88.

Items per page

Supplemental Content

Support Center